Sichuan Xieli Pharmaceutical Co., Ltd. has secured a Bronze rating in the latest EcoVadis sustainability assessment published in July 2026. Boasting a comprehensive score of 72 out of 100, Xieli stood out with a robust sustainability management framework. Its overall performance ranks among the top 18% of all participating enterprises worldwide and 82nd within its industry. This accreditation serves as authoritative international recognition of the company’s social responsibility governance across four core pillars: environmental protection, labour & human rights, ethics, and sustainable procurement.
The assessment certificate is valid from July 6, 2026 to July 6, 2027. It evaluates our sustainable operation capacity across four core dimensions. Our strong scores in each segment fully demonstrate our long-standing commitment and solid track record in green pharmaceutical production and fully compliant business practices:
1. Environmental Performance: Underpinning Eco-Friendly Pharmaceutical Manufacturing: Environmental protection carries the highest weighting in this assessment. As a pharmaceutical manufacturer, we embed green and low-carbon practices throughout the entire production chain. We have established standardized environmental management workflows covering closed-loop hazardous material control, compliant treatment of waste water, waste gas and solid waste, energy-saving technical upgrades, carbon footprint tracking and clean production systems. These efforts steadily reduce the environmental footprint of our manufacturing operations, as we deliver tangible progress toward the green transition of the pharmaceutical sector.
2. Labour & Human Rights: Putting People First to Safeguard Employee Interests
We comply strictly with international labour standards and domestic employment regulations, and have built a comprehensive employee welfare system. We maintain standardized compensation and benefits packages, full occupational health and safety protection, equitable employment practices, regular safety training sessions, and open communication channels for all staff. These measures fully protect every employee’s legal rights and foster a safe, fair and inclusive modern workplace.
3. Business Ethics: Upholding Industry Integrity Through Compliant Operations: We have rolled out standardized governance for business ethics with permanent internal controls targeting anti-bribery, anti-corruption, transparent operation and supply chain compliance audits. Robust internal oversight and whistleblowing channels are in place to uphold fair and honest business principles, building a solid compliance barrier and setting a benchmark for integrity within the pharmaceutical industry.
4. Sustainable Procurement: Building a Green Supply Chain With Partners Up and Downstream: We keep refining our sustainable procurement framework by embedding environmental, labour and compliance requirements into supplier admission, evaluation and full-lifecycle management procedures. We select high-quality eco-conscious partners and push raw material suppliers to align with sustainability standards, forming a fully integrated green pharmaceutical supply chain that delivers coordinated growth across the whole industry chain.
EcoVadis stands as the world’s most widely recognized third-party platform for corporate sustainability assessments, serving over 100,000 enterprises across the globe. Its evaluation framework aligns with leading global sustainability benchmarks including the Universal Declaration of Human Rights, ISO environmental standards and international anti-bribery conventions. Ratings issued by EcoVadis serve as a core reference for international buyers and multinational supply chains when selecting manufacturing partners. This Bronze Rating accreditation delivers authoritative validation of Sichuan Xieli Pharmaceutical’s achievements in sustainability governance. It also provides powerful endorsement for our company as we expand overseas markets, acquire global clients and strengthen brand competitiveness on the international stage.
Building on this milestone, Sichuan Xieli will leverage this EcoVadis assessment as a catalyst for further improvement. We will keep advancing our four core sustainability pillars: eco-friendly production, people-centric management, ethical operation and collaborative supply chain governance. Upholding higher corporate social responsibility standards, we will deliver pharmaceutical products that combine premium quality with sustainable value, and steadily strive toward Silver and even Gold ratings in the future.
